Related Experiment Video

Updated: Jan 6, 2026

Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes
08:49

Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes

Published on: March 14, 2021

4.5K

The Roles And Signaling Pathways Of Phosphatidylethanolamine-Binding Protein 4 In Tumors

Zi-Kang Luo1, Qiong-Feng Chen2, Xiaoqin Qu2

  • 1Department of Clinical Medical, The Second Clinical Medical College, Nanchang University, Nanchang 330006, People's Republic of China.

Oncotargets and Therapy
|October 2, 2019
PubMed

Insights

Phosphatidylethanolamine-binding protein 4 (PEBP4) is highly expressed in tumors, promoting cancer cell proliferation, metastasis, and therapeutic resistance. Targeting PEBP4 offers potential for individualized cancer treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Phosphatidylethanolamine-binding protein 4 (PEBP4) is frequently overexpressed in various human cancers.
  • PEBP4 plays a significant role in tumor progression, including proliferation, differentiation, and metastasis.
  • The protein is implicated in cancer-activated signaling pathways and contributes to therapeutic resistance.

Purpose of the Study:

  • To review the morphological structure and expression patterns of PEBP4 in cancer.
  • To discuss the role of PEBP4 in the personalized treatment of specific cancers.
  • To explore the potential of PEBP4 as a therapeutic target for cancer treatment.

Main Methods:

  • Literature review of PEBP4 expression and function in tumors.
  • Analysis of signaling pathways influenced by PEBP4 in different cancer types.
  • Evaluation of PEBP4's role in therapeutic resistance.

Main Results:

  • Overexpression of PEBP4 correlates with enhanced cancer cell proliferation and metastasis.
  • PEBP4 contributes to resistance against radiotherapy and chemotherapy.
  • Key signaling pathways affected by PEBP4 in various cancers were identified.

Conclusions:

  • PEBP4 is a critical factor in promoting cancer aggressiveness and treatment failure.
  • Targeting PEBP4 presents a promising avenue for developing novel, individualized cancer therapies.
  • Further research into PEBP4's mechanisms can lead to improved therapeutic strategies.
Keywords:
PEBP4signaling pathwaytargeted therapy

More Related Videos

In Vitro Assay to Measure Phosphatidylethanolamine Methyltransferase Activity09:33

In Vitro Assay to Measure Phosphatidylethanolamine Methyltransferase Activity

Published on: January 5, 2016

10.2K
Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.6K

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.6K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.0K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
16.9K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.8K